TrialFrontiers in pharmacology2026

Safety, tolerability, pharmacokinetics, and pharmacodynamics of zapnometinib: results from a phase I clinical study.

Stephan Stenglein et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.